by : dr.a.r.mobaien dr. mobaien a.r. dr. mobaien a.r. md - mph severe sepsis and septic shock

Download By : Dr.A.R.Mobaien Dr. Mobaien A.R. Dr. Mobaien A.R. MD - MPH SEVERE SEPSIS AND SEPTIC SHOCK

If you can't read please download the document

Upload: deirdre-stokes

Post on 23-Dec-2015

216 views

Category:

Documents


2 download

TRANSCRIPT

  • Slide 1
  • By : Dr.A.R.Mobaien Dr. Mobaien A.R. Dr. Mobaien A.R. MD - MPH SEVERE SEPSIS AND SEPTIC SHOCK
  • Slide 2
  • By : Dr.A.R.Mobaien = =
  • Slide 3
  • By : Dr.A.R.Mobaien : .
  • Slide 4
  • By : Dr.A.R.Mobaien 1992 The Society of Critical Care Medicine The American College of Chest Physicians
  • Slide 5
  • By : Dr.A.R.Mobaien SIRS = : 38.3 36 90 20 PaCO2 < 32 mmHg 12000 4000 (Band Cell) 10%
  • Slide 6
  • By : Dr.A.R.Mobaien SEPSIS = SIRS + evidence of infection SEVERE SEPSIS = : SEPTIC SHOCK = ( 90 40 ) 500 If septic shock lasts for >1 hr and does not respond to pressor administration, the term refractory septic shock is often used.
  • Slide 7
  • By : Dr.A.R.Mobaien
  • Slide 8
  • Mechanisms that sense bacteria and initiate host responses
  • Slide 9
  • By : Dr.A.R.Mobaien
  • Slide 10
  • Normal Systemic Responses toInfection and Injury: Presumed Contributions to Host Defense
  • Slide 11
  • By : Dr.A.R.Mobaien pathogenesis the pathogenesis of severe sepsis may differ according to the: the pathogenesis of severe sepsis may differ according to the: infecting microbe, the site of the primary infection, the presence or absence of immune defects, the prior physiologic status of the host. Genetic factors may also be important.
  • Slide 12
  • By : Dr.A.R.Mobaien
  • Slide 13
  • Slide 14
  • Slide 15
  • Inflammation-activated coagulation
  • Slide 16
  • By : Dr.A.R.Mobaien
  • Slide 17
  • PIRO Staging of Sepsis From Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ ATS/SIS International sepsis definitions conference. Crit Care Med 2003;31:12501256.
  • Slide 18
  • By : Dr.A.R.Mobaien CLINICAL MANIFESTATIONS patients underlying illness and primary infection signs and symptoms develop may differ from patient to patient the absence of fever is most common in: neonates, in elderly patients, in persons with uremia or alcoholism.
  • Slide 19
  • By : Dr.A.R.Mobaien Hyperventilation is often an early sign. Hyperventilation is often an early sign. Disorientation, confusion, and other manifestations of may also develop early in the septic response Disorientation, confusion, and other manifestations of encephalopathy may also develop early in the septic response
  • Slide 20
  • Plasma Lipids High-density lipoprotein (HDL) and low-density lipoprotein (LDL) levels decrease High-density lipoprotein (HDL) and low-density lipoprotein (LDL) levels decrease Triglyceride, free fatty acid, and very low- density lipoprotein (VLDL) levels increase Triglyceride, free fatty acid, and very low- density lipoprotein (VLDL) levels increase The decrease in serum cholesterol is almost entirely accounted for by lower concentrations of cholesterol esters in circulating HDL and LDL The decrease in serum cholesterol is almost entirely accounted for by lower concentrations of cholesterol esters in circulating HDL and LDL By : Dr.A.R.Mobaien
  • Slide 21
  • skin lesions may suggest specific pathogens. cutaneous petechiae or purpura (Neisseria meningitidis) cutaneous lesion seen almost exclusively in neutropenic patients is ecthyma gangrenosum, usually caused by P. aeruginosa. Hemorrhagic or bullous lesions in who has recently eaten raw oysters suggest Vibrio vulnificus bacteremia patient who has recently suffered a dog bite may indicate bloodstream infection due to Capnocytophaga canimorsus Generalized erythroderma in a septic patient suggests the toxic shock syndrome due to S. aureus or S. pyogenes.
  • Slide 22
  • By : Dr.A.R.Mobaien Neisseria meningitidis
  • Slide 23
  • By : Dr.A.R.Mobaien Neisseria meningitidis
  • Slide 24
  • By : Dr.A.R.Mobaien P. aeruginosa.
  • Slide 25
  • By : Dr.A.R.Mobaien Vibrio vulnificus
  • Slide 26
  • By : Dr.A.R.Mobaien MAJOR COMPLICATIONS ARDS develops in 50% of patients with severe sepsis or septic shock. fluid volume overload or cardiac failure Depression of myocardial function, manifested as increased end diastolic and systolic ventricular volumes with a decreased ejection fraction, develops within 24 h in most patients with severe sepsis. refractory hypotension is usually due to a low systemic vascular resistance
  • Slide 27
  • By : Dr.A.R.Mobaien Renal Complications Oliguria, azotemia, proteinuria, and nonspecific urinary casts Oliguria, azotemia, proteinuria, and nonspecific urinary casts Most renal failure is due to Most renal failure is due to acute tubular necrosis some patients also have: some patients also have: glomerulonephritis, renal cortical necrosis, interstitial nephritis
  • Slide 28
  • By : Dr.A.R.Mobaien Coagulation Thrombocytopenia (10 to 30%) DIC ( lower than 50,000/L)
  • Slide 29
  • By : Dr.A.R.Mobaien Noninfectious etiologies of SIRS pancreatitis, burns, trauma, adrenal insufficiency, pulmonary embolism, dissecting or ruptured aortic aneurysm, myocardial infarction, occult hemorrhage, cardiac tamponade, post-cardiopulmonary bypass syndrome, anaphylaxis, drug overdose.
  • Slide 30
  • By : Dr.A.R.Mobaien
  • Slide 31
  • blood cultures negative antibiotic administration, the presence of slow-growing or fastidious organisms, the absence of microbial invasion of the bloodstream
  • Slide 32
  • By : Dr.A.R.Mobaien
  • Slide 33
  • TREATMENT
  • Slide 34
  • By : Dr.A.R.Mobaien TREATMENT Respiratory Therapy Circulatory Therapy Transfusion of Erythrocytes and Erythropoietin Drugs Antibiotics Corticosteroids Recombinant Human Activated Protein C Controversial Therapies in Septic Shock Vasopressin Deficiency and Use of Vasopressin Hyperglycemia and Intensive Insulin Therapy Renal Dysfunction and Dialysis Other Therapies(Deep vein thrombosis prophylaxis using low-dose heparin, Stress ulcer prophylaxis using H2-receptor antagonists, Enteral nutrition is generally safer and more effective than total parenteral nutrition
  • Slide 35
  • By : Dr.A.R.Mobaien Identify the Cause and Source of Infection Identify the Cause and Source of Infection Initiate Appropriate Antibiotic Therapy Initiate Appropriate Antibiotic Therapy Restore and Maintain Hemodynamic Function Restore and Maintain Hemodynamic Function Support Oxygenation and Ventilation Support Oxygenation and Ventilation Antithrombotic, Profibrinolytic, Anti-inflammatory Therapy Antithrombotic, Profibrinolytic, Anti-inflammatory Therapy Metabolic Support Metabolic Support Maintain early nutritional support. Maintain intestinal mucosa barrier function by enteral route, the preferred method. Control hyperglycemia to decrease infectious complications, may need IV insulin therapy. Prevent Complications of Critical Illness Prevent Complications of Critical Illness CURRENT THERAPY
  • Slide 36
  • By : Dr.A.R.Mobaien TREATMENT Anticoagulant Agents aPC for use in adults ( >18 years of age) who meet the APACHE II 25 during the 24h before initiation of aPC infusion Contraindications Intracranial hemorrhage platelet counts of < 30,000/ L meningitis
  • Slide 37
  • By : Dr.A.R.Mobaien
  • Slide 38
  • Slide 39
  • Definition of Sequential Organ Failure Assessment (SOFA) scores
  • Slide 40
  • By : Dr.A.R.Mobaien Empirical Antibiotic Options for Patients with Severe Sepsis or Septic Shock
  • Slide 41
  • By : Dr.A.R.Mobaien
  • Slide 42
  • PROGNOSIS(30 day) Approximately 20 to 35% of patients with severe sepsis 40 to 60% of patients with septic shock Die
  • Slide 43
  • By : Dr.A.R.Mobaien
  • Slide 44
  • Slide 45
  • Slide 46
  • Slide 47
  • Slide 48
  • Slide 49
  • Slide 50
  • Slide 51
  • Sepsis By: Dr. Ahmadreza Mobaien MD - MPH